financetom
Business
financetom
/
Business
/
Gunmaker Colt to buy $1 billion Czech nitrocellulose company
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Gunmaker Colt to buy $1 billion Czech nitrocellulose company
Aug 29, 2025 12:31 AM

PRAGUE (Reuters) -Czech-based firearms maker Colt CZ Group SE has agreed to buy Czech nitrocellulose maker Synthesia Nitrocellulose in two stages in a transaction valuing the target at 22 billion crowns ($1.05 billion), Colt said on Friday.

Colt, which also has operations in the United States, Canada, Sweden, Switzerland and Hungary, said the acquisition from privately owned chemicals group Synthesia would help to secure its supply chain and expansion into larger calibres in high demand.

Nitrocellulose is a raw material needed for ammunition production.

"The acquisition ... fits into our strategy of expanding the group's activities into medium and large-calibre ammunition while strengthening our position in a critical element of our supply chain," Colt Chairman Jan Drahota said in a statement.

"We intend to continue the vertical integration of ammunition manufacturing, thereby contributing to the strategic independence and self-sufficiency of the Czech Republic and NATO countries in defence supplies."

In the first stage, Colt will take 51% stake in a cash-and-shares deal to be settled after regulatory approvals expected by the end of the first quarter of 2026, it said.

The portion of the first stage of the deal covered with new shares will be about 40%, making Synthesia owner Kaprain, the third largest shareholder in Colt, it said.

The remaining stake will be purchased in "the medium term", it added.

The total transaction price of 22 billion crowns, based on enterprise value, corresponds to about 8.2 times expected 2025 core profit, Colt said.

Colt also said it will acquire Synthesia's power production business in a deal with an enterprise value of 1.4 billion crowns, to be paid entirely through new Colt shares.

($1 = 20.9570 Czech crowns)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
PyroGenesis Closed First Tranche of First Unit Group In Non-Brokered Private Placement for Near $3.5 Million
PyroGenesis Closed First Tranche of First Unit Group In Non-Brokered Private Placement for Near $3.5 Million
Oct 16, 2025
07:17 AM EDT, 10/16/2025 (MT Newswires) -- PyroGenesis ( PYRGF ) , a player in innovating for ultra-high temperature processes and engineering, and a technology provider to heavy industry & defense, announced Thursday that it has completed the first tranche of the First Unit Group in previously announced non-brokered private placement by issuing and selling an aggregate of 5,555,556 units...
NGEx Minerals Sets Oct. 23 Closing for Spin-Out of LunR Royalties; Raises $175 Million in Private Placement
NGEx Minerals Sets Oct. 23 Closing for Spin-Out of LunR Royalties; Raises $175 Million in Private Placement
Oct 16, 2025
07:17 AM EDT, 10/16/2025 (MT Newswires) -- NGEx Minerals ( NGXXF ) , trading shy of 52-week highs, announced Thursday, the expected closing date of its previously announced spin-out transaction, pursuant to which it will spin-out net smelter returns royalties on the Lunahuasi and Los Helados Projects into a wholly-owned unit of NGEx, LunR Royalties, by way of a statutory...
Novartis' Phase 3 Study of Fabhalta in IgA Nephropathy Meets Primary Endpoint
Novartis' Phase 3 Study of Fabhalta in IgA Nephropathy Meets Primary Endpoint
Oct 16, 2025
07:16 AM EDT, 10/16/2025 (MT Newswires) -- Novartis ( NVS ) said Thursday that its phase 3 study of Fabhalta in adults with IgA nephropathy kidney disease, or IgAn, met its primary endpoint. The achieved primary endpoint is a statistically significant improvement in estimated glomerular filtration rate, or eGFR, slope compared with placebo over two years, the company said, noting...
Wipro Fiscal Q2 Earnings, Revenue Rise
Wipro Fiscal Q2 Earnings, Revenue Rise
Oct 16, 2025
07:15 AM EDT, 10/16/2025 (MT Newswires) -- Wipro ( WIT ) reported fiscal Q2 earnings Thursday of 3.09 Indian rupees ($0.03) per diluted share, up from 3.06 rupees a year earlier. Four analysts polled by FactSet expected 3.11 rupees. Revenue for the quarter ended Sept. 30 was 226.97 billion rupees, up from 223.02 billion rupees a year earlier. Analysts surveyed...
Copyright 2023-2026 - www.financetom.com All Rights Reserved